MedTech News

CathVision Receives CE Mark for ECGenius System, Advancing Cardiac Monitoring and Analytics Technology in Europe
COPENHAGEN, Denmark, Feb. 19, 2025 /PRNewswire/ — CathVision, a medical technology company developing advanced electrophysiology solutions, is proud to announce that it has received CE Mark for its breakthrough product, ECGenius System. This regulatory milestone allows CathVision to market and distribute ECGenius System across the European Economic Area (EEA), bringing state-of-the-art electrophysiology solutions to healthcare providers and patients.

MIT spinout maps the body’s metabolites to uncover the hidden drivers of disease
ReviveMed uses AI to gather large-scale data on metabolites — molecules like lipids, cholesterol, and sugar — to match patients with therapeutics.

Scientists develop new natural killer cell strategy to target HIV
Researchers at The Wistar Institute’s HIV Cure and Viral Diseases Center have successfully identified a new approach using natural killer (NK) cells to target and kill the HIV-positive cells that allow the virus to persist. Wistar scientists have labeled this new approach “NuKES”: Natural Killer Enhancement Strategy.

Using CRISPR to remove extra chromosomes in Down syndrome
Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro proof-of-concept study.

Scientists develop ‘smart pajamas’ to monitor sleep disorders
Researchers have developed comfortable, washable “smart pajamas” that can monitor sleep disorders such as sleep apnea at home, without the need for sticky patches, cumbersome equipment or a visit to a specialist sleep clinic.

Scientists decode diet from stool DNA, no questions asked
Scientists have developed a breakthrough method to track diet using stool metagenomic data.

Multiple sclerosis: Cell-catching implant helps identify successful treatment in mice
A sponge-like implant in mice has helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It has also given University of Michigan researchers a first look at how primary progressive multiple sclerosis, the fastest-progressing version of the disease, attacks the central nervous system early on.

AESOP Technology Unveils World’s First Machine Learning Model to Combat Wrong-Site Surgery
SAN FRANCISCO, Feb. 18, 2025 /PRNewswire/ — Wrong-site surgery (WSS), a critical “Never Event,” represents a failure that should never occur in healthcare. Yet, due to underreporting, the true prevalence of these incidents remains obscured, jeopardizing patient safety and healthcare management. AESOP Technology, a medical AI startup, has developed an innovative solution: the Association Outlier Pattern (AOP) machine learning model. This model offers real-time decision support and retrospective analysis, aimed at enhancing surgical safety and care quality.